While the latter studies were mainly focused on SSc dermal fibroblasts, our group confirmed the reduced expression of SFRP1 and DKK1, coupled with Wnt overexpression, in SSc lung fibroblasts, supporting the protective role of these Wnt antagonists also in SSc lung fibrosis [14]. The gene discussed is SFRP1; the disease is systemic sclerosis.